三个皮匠报告
最新
报告分类 研搜
热门标签
BETA
政策库
自研报告
new
入驻
搜索

中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例-行业数据

中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例
中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例
目前，大部分中国前列腺癌患者就诊时即为晚期，新发病例中在确诊时仅 30%为临床局限型患者，余者均为局部晚期或广泛转移的患者，这些患者无法接受局部的根治性治疗，预后较差。而美国的新发病例中，确诊时有约 80%为临床局限型患者，超过了中国的两倍。
行业数据 下载图片 原图定位
图片属性
图片格式：PNG 图片大小：140KB 图片尺寸：1594*751
同报告图片
 / 4
中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例_第1页
fCDkuK3lm73lkoznvo7lm73liY3liJfohbrnmYzkupTlubTnlJ/lrZjnjoflr7nmr5QgfCDkuK3lm70gfCDnvo7lm70gfAp8LS0tfC0tLXwtLS18Cnwg55Sf5a2Y546HIHwgNjYuNCUgfCA5OC4yJSB8Cgp8IOS4reWbveWSjOe+juWbveaZmuacn+WJjeWIl+iFuueZjOeXheS6uuavlOS+iyB8IOS4reWbvSB8IOe+juWbvSB8CnwtLS18LS0tfC0tLXwKfCDnl4Xkurrmr5TkvosgfCA3MC4wJSB8IDIwLjAlIHwKCui1hOaWmeadpea6kO+8mkZyb3N0JlN1bGxpdmFu77yM5YWs5Y+45oub6IKh6K+05piO5Lmm77yM5YWJ5aSn6K+B5Yi456CU56m25omA
中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例_第2页
中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例_第3页
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
中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例_第4页
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
中国和美国前列腺癌五年生存率对比及晚期前列腺癌病人比例_第5页
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
所属报告： 海创药业：良药济世以氘代、PROTAC赋能研发的国际化Biotech-220916（39页）.pdf
打包全文图表
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
  • 友链申请 (QQ)：1737380874
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
友情链接：
营销自动化 亿欧智库 微播易 阿里妈妈
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠